|
|
|
|
|
|
| Abstract Search | Browse Program and Abstracts | Schedule-at-a-Glance | Conference Mission & Sponsors | Program Committee | Contact Us |
| # | Title |
|---|---|
| 75 | Measurement of Vaccination-Induced Cell-Mediated Immunity by in Vitro CMI
J. B. Woodcock*1, N. Hooper1, R. Kowalski1, A.-C. Leandersson2, B. Wahren2, and J. Britz1 1Cylex Inc., Columbia, MD, USA and 2Karolinska Inst., Stockholm, Sweden |
| 76 | A Panel of MHC Class I Restricted Viral Peptides for Use as a Control for Vaccine Trial ELISPOT Assays
E. Kuta*1, J. Currier1, E. Turk1, L. Loomis-Price1, G. Ferrari2, S. Janetzki3, D. Birx1, and J. Cox1 1The US Military HIV Res. Program, Rockville, MD, USA; 2Duke Univ., Durham, NC, USA; and 3Zellnet Consulting, New York, NY, USA |
| 77 | Comparison of Multiple Analytical Methods to Measure Cytokine Production from Single T Cells
R. P. Bucy*1, G. Marshall1, P. Goeptfert1, J. Jacobson2, and J. M. Kilby1 1Univ. of Alabama at Birmingham, USA and 2Mount Sinai Med. Ctr., New York, NY, USA |
| 78 | Alternative Peptide Analogues (“Mimic Peptides”) of the HIV-1-Gag J. Kan-Mitchell*1, M. Bereta1, B. Bisikirska1, S. E. Blondelle2, C. Boggiano2, and D. B. Wilson2 1Karmanos Cancer Inst., Wayne State Univ. Sch. of Med., Detroit, MI, USA and 2Torrey Pines Inst. of Mol. Studies, San Diego, CA, USA |